SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David S. who wrote (3672)1/26/1998 1:16:00 PM
From: Joe E.  Read Replies (2) of 6136
 
Re your feeling of worthlessnes:

You will never be worthless so long as your modem works.

Re chicken soup:
It is cheap (especially in Hong Kong) but does not have FDA approval. If it did have FDA approval, it would not be cheap (except in Hong Kong).

Re Agouron:
European approval is very good, as it reinforces the probability that the forecasts by the analysts will be met. Two big uncertainties remain: the lifespan of Viracept as a leadng treatment for HIV infection and the success of the drugs in the pipeline. Neither of these will be obvious for some time. You and John will have years to snipe. In the shorter term, the important conference starting next week has a web site:
retroconference.org
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext